Affecting more than 150 million patients worldwide, age-related macular degeneration (AMD) is a leading cause of blindness in the world. AMD causes blurry vision or blindness, particularly in the central field of vision, as deposits of lipid or fatty proteins begin to accumulate under the retina. There are two forms of AMD — “wet” and “dry,” with the wet form representing a more advanced stage of the disease.
Early detection through routine eye exams is key, and there are some treatments available to help prevent or slow the progression of vision loss.
(In fact, Mass. Eye and Ear/Harvard Medical School researchers developed the first pharmaceutical treatment approved by the U.S. Food and Drug Administration for the wet form of AMD, and they conducted groundbreaking research that led to current anti-VEGF treatments. They’ve also been exploring some promising new therapies to control the dry form.)
As part of a video series launched during AMD Awareness Month, the Angiogenesis Foundation sat down with Deeba Husain, M.D., a retina specialist at Mass. Eye and Ear, who offered further insight on protecting your vision from AMD.
Check out the video above, and, if it’s been a while, remember to schedule your dilated eye exam.